Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep580 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Homozygous familial hypercholesterolemia with resistance to Inclisiran (siRNA PCSK9i) – a case report

Michel Melina , Walha Hela , Barigou Mohammed

Introduction: Homozygous familial hypercholesterolemia (HoFH) is a rare inherited autosomal dominant disease (1/20000 Individuals) involving germline mutations in the LDL metabolism pathways (LDL receptor/PCSK9/APOB/lDLRAP) that results in very high levels of LDLc, usually >10 mmol/l, and premature cardiovascular disease. The EAS guidelines recommend the use of PCSK9 inhibitors (PCSK9i) as a third line therapy in HoFH, however they report no precision regarding the effect ...

ea0099ep1274 | Late Breaking | ECE2024

From high dose Insulin therapy to dual oral therapy: recovery from glucotoxicity after acute pancreatitis and severe ketoacidotic hyperglycaemia

Al Sahaf Hassan , AlMahrous Lama , Mohammed Azmi

Significant hyperglycaemia suppresses beta cell replication and cell cycle progression. Acute beta cell failure is caused by several mechanisms involving oxidative and endoplasmic stress leading to DNA damage response (collectively termed glucotoxicity) (1). Short-term glycaemic control unmasks the regenerative potential of beta cells, leading to recovery and potentially weaning off Insulin therapy (1, 2, 3). We present a case of a 62-year-old woman with ...

ea0099ep1324 | Late Breaking | ECE2024

Endocrine osteoporosis: report of a series of cases

Mohammed Amine Essafi , Hayat Aynaou , Houda Salhi

Background and aims: Endocrine osteoporosis should be uncommon in contemporary times due to improved early diagnosis of endocrinopathies. Our objective is to analyze the osteodensitometric profiles of patients under endocrinopathy care.Methods: A cross-sectional study of patients followed for endocrinopathies at the Endocrinology Department of the Hassan II University Hospital of Fez, spanning from the beginning of January 2016 to January 2022. Exclusion...

ea0090p518 | Thyroid | ECE2023

Cerebral Vascular Accident in a patient presenting with a Thyroid Storm

Mohamed Ayan , Bashir Mahamud , Ramachandran Kirtanya , Etbinah Lubna , Mohammed Mohammed , Roy Juthi , Mlawa Gideon

Thyroid storm is rare life-threatening clinical manifestation of endocrine dysfunction originating from excess level of thyroid hormone leading to hypermetabolic state with an incidence of 0.57-0.76/1000,000. The increase demand of metabolic activity subsequently induces, palpitations, dyspnoea, exercise intolerance and congestive heart failure. Most common cardiovascular manifestation of thyroid storm is tachycardia and atrial fibrillation occurs in up to 15% of patients. In ...

ea0090ep113 | Adrenal and Cardiovascular Endocrinology | ECE2023

A case of autoimmune polyglandular syndrome type 2 unmasked after treating subclinical hypothyroidism

Bashir Mahamud , Oyesanya Ayodeji , Mohammed Mohammed , Mohamed Ayan , Etbinah Lubna , Ramachandran Kirtanya , Mlawa Gideon

Background: Autoimmune polyglandular syndrome type 2 is an autoimmune disorder that affects many hormone-producing (endocrine) glands. It is characterized by the presence of Addison’s disease along with autoimmune thyroid disease and/or type 1 diabetes. The initial presentation can be varied but some patient maybe present with subclinical hypothyroidism and later develop Addisonian crisis. The pathogenesis of Autoimmune polyglandular syndrome type 2 remains unclear, altho...

ea0090ep879 | Pituitary and Neuroendocrinology | ECE2023

Pituitary Tumours and Learning Difficulties-An Association or Incidental Finding?

Bashir Mahamud , Etbinah Lubna , Oyesanya Ayodeji , Ramachandran Kirtanya , Mohammed Mohammed , Karaca Anara , Mlawa Gideon

Introduction: Pituitary tumours one of the most commonly occurring intracranial neoplasms accounting for up to the 15 % of all intracranial neoplasms. Pituitary tumours are often associated with overproduction of hormones or, when they are large, they cause mass effect on surrounding neural structures which are adjacent to their typical location in the Sella turcica. Due to their multifaceted effects pituitary tumours may cause cognitive impairment due hormonal deficiency or m...

ea0090ep922 | Reproductive and Developmental Endocrinology | ECE2023

Association of Bardet-Biedl syndrome with Differences of Sex Development and pituitary hypoplasia

Benammar Ammar Soraya , Benabadji Nadjia , Mahieddine Benghani Mohammed , El Amine Amani Mohammed

Introduction: Bardet-Biedl syndrome (BBS) is a rare autosomal recessive genetic disorder involving hypogonadism manifested by cryptorchidism, micropenis and/or delayed pubertyObservation: We report the case of a 13 year old child, who was consulted for obesity and whose physical examination showed major signs of SBB: global obesity, polydactyly, learning difficulties and visual disorders. Genital examination revealed a 1 cm genital tubercle with a single...

ea0099p455 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Effect of prior GLP-1 RA treatment on clinical outcomes in patients with type 2 diabetes initiating treatment with tirzepatide

Suliman Mohammed , Buckley Adam , Allum Matthew , Lessan Nader , Mohammed Nagi , le Roux Carel , Suliman Sara

Background: Tirzepatide is a GLP-1/GIP co-agonist treatment for type 2 diabetes. Participants in the SURPASS trials were GLP-1RA naïve, but in clinical practice many patients are switched from other GLP-1RAs.Aims: To explore effects of prior GLP-1RA treatment on tirzepatide therapy outcomes.Methods: Review of clinical data from an outpatient Diabetes centre. Adults with 6 months follow-up post tirzepatide initiation were inclu...

ea0051p021 | Miscellaneous/other | BSPED2017

Novel splicing mutation in B3GAT3 associated with short stature, GH deficiency, hypoglycaemia, developmental delay and multiple congenital anomalies

Bloor Samuel , Giri Dinesh , Didi Mohammed , Senniappan Senthil

Introduction: B3GAT3, encoding β-1,3-glucuronyltransferase 3, has an important role in proteoglycan biosynthesis. Homozygous B3GAT3 mutations have been associated with short stature, skeletal deformities and congenital heart defects. We describe for the first time, a novel heterozygous splice site mutation in B3GAT3 contributing to severe short stature, growth hormone (GH) deficiency, recurrent ketotic hypoglycaemia, facial dysmorphism and conge...

ea0081p107 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The relation between insulin resistance and both growth hormone and insulin-like growth factor (IGF-1) levels in a sample of Iraqi patients with type 2 diabetes

Mohammed Alrubyae Hasanain , Al-Saffar Araz , Allehibi Khalid

Introduction Background: Over the last decade, scientific attention has been drawn to the potential role of Growth hormone (GH) and Insulin Like Growth Factor-1 (IGF-1) in the pathogenesis and progression of T2DM. Both hormones are interrelated but exert variable effect on glucose homeostasis. While GH increases blood glucose level, IGF-1 maintain insulin secretion and enhance insulin sensitivity.Methods: A cross sectional study conducted in the National...